In the wake of Arrowhead Pharmaceuticals, Inc.s latest US108m market cap drop, institutional owners may be forced to take severe actions
| ARWR Stock | USD 19.23 0.30 1.54% |
Slightly above 62% of Arrowhead Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Arrowhead Pharmaceuticals suggests that many traders are alarmed. Arrowhead Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in Arrowhead Pharmaceuticals. Many technical investors use Arrowhead Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Arrowhead |
Key Insights Given the large stake in the stock by institutions, Arrowhead Pharmaceuticals stock price might be...
Read at simplywall.st
 |
Arrowhead Pharmaceuticals Fundamental Analysis
We analyze Arrowhead Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Arrowhead Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Arrowhead Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Operating Margin
Operating Margin Comparative Analysis
Arrowhead Pharmaceuticals is currently under evaluation in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Arrowhead Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Arrowhead Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Arrowhead Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Arrowhead Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Arrowhead Pharmaceuticals Related Equities
| ASMB | Assembly Biosciences | 7.86 | ||||
| AMLX | Amylyx Pharmaceuticals | 4.58 | ||||
| PRQR | ProQR Therapeutics | 2.56 | ||||
| WVE | Wave Life | 2.32 | ||||
| TERN | Terns Pharmaceuticals | 1.35 | ||||
| ANNX | Annexon | 0.78 | ||||
| BPMC | Blueprint Medicines | 0.15 | ||||
| INCY | Incyte | 0.13 | ||||
| IONS | Ionis Pharmaceuticals | 0.28 | ||||
| CTMX | CytomX Therapeutics | 1.45 | ||||
| APLS | Apellis Pharmaceuticals | 2.12 | ||||
| BMRN | Biomarin Pharmaceutical | 3.32 | ||||
| DAWN | Day One | 16.50 |
Additional Tools for Arrowhead Stock Analysis
When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.